• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail

FDA Issues a Notice of the Availability of Safety and Effectiveness Data to Support a Minor Species New Animal Drug Application

March 20, 2009

The Food and Drug Administration (FDA) today is announcing the availability of a Public Master File (PMF) containing safety and effectiveness data to support a new animal drug application (NADA) or supplemental NADA for use of the progesterone insert (CIDR) for induction of estrus in ewes (sheep) during seasonal anestrous.

These data have been reviewed by FDA’s Center for Veterinary Medicine (CVM) and demonstrate the safety and effectiveness of this product. They may be used by pharmaceutical sponsors at no cost to support the approval of this product along with the additional manufacturing, labeling, and other required information to constitute a complete NADA. Today’s announcement is not for the approval of this product - only that data are available to support a pharmaceutical sponsor’s new animal drug application.

The data, contained in Public Master File (PMF) 5947, were compiled by researchers at the National Research Support Project 7 (NRSP–7), a national agricultural research program that facilitates generation of data to support FDA approval of new drugs for minor animal species and for minor uses in the major species.

FDA is providing the data in advance of the Federal Register publication in order to make the information available to potential sponsors as quickly as possible. Please see the Notice of Availability.

For additional information on animal drugs for minor uses and minor species, please see http://www.fda.gov/cvm/minortoc.htm.


Contact FDA

240-276-9115 FAX
Issued by: FDA, Center for Veterinary Medicine

Communications Staff, HFV-12

7519 Standish Place

Rockville, MD 20855